1. Is cystic fibrosis survival improving in excess to that of the general population for England and Wales and the USA?. (24th May 2012) Authors: Hurley, MN; McKeever, T; Prayle, AP; Fogarty, A; Smyth, AR Journal: Archives of disease in childhood Issue: Volume 97(2012)Supplement 1 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P117 Does the differential measurement error of pulse oximeters in patients with non-white skin delay the initiation of oxygen therapy?. (11th November 2022) Authors: Williams, M; Holt, R; Churchill, J; Singh, R; Shaw, D; Fogarty, A Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P92 Systemic alkyl quinolones as novel biomarkers for pulmonary exacerbations in cystic fibrosis: a validation study. (15th November 2016) Authors: Barr, H; Fogarty, A; Halliday, N; Knox, A; Quon, B; Forrester, D; Williams, P; Barrett, D; Camara, M Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S17 A prothrombotic state is associated with increased mortality in idiopathic pulmonary fibrosis. (14th November 2013) Authors: Navaratnam, V; Fogarty, A; McKeever, T; Thompson, N; Jenkins, RG; Johnson, SR; Dolan, G; Kumaran, M; Pointon, K; Hubbard, RB Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival?. (16th November 2010) Authors: Navaratnam, V; Ali, N; Smith, CJP; Fogarty, A; Hubbard, R B Journal: Thorax Issue: Volume 65(2010)Supplement 4 Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S97 Is an Increased Tendency to Clot a Risk Factor For Developing Idiopathic Pulmonary Fibrosis?. (19th November 2012) Authors: Navaratnam, V; Fogarty, A; McKeever, T; Thompson, N; Jenkins, RG; Johnson, SR; Dolan, G; Kumaran, M; Pointon, K; Hubbard, RB Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The developing story of antioxidants and asthma. Issue 1 (23rd December 2003) Authors: Hubbard, R; Fogarty, A Journal: Thorax Issue: Volume 59:Issue 1(2004) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The rising incidence of idiopathic pulmonary fibrosis in the UK. Issue 6 (27th April 2011) Authors: Navaratnam, V; Fleming, K M; West, J; Smith, C J P; Jenkins, R G; Fogarty, A; Hubbard, R B Journal: Thorax Issue: Volume 66:Issue 6(2011) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Issue 8 (28th July 2004) Authors: Pearson, P J K; Lewis, S A; Britton, J; Fogarty, A Journal: Thorax Issue: Volume 59:Issue 8(2004) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗